BACKGROUND: Expression of the key iron regulatory hormone hepcidin is increased by some stimuli (iron loading, inflammation) but decreased by others (increased erythropoiesis, iron deficiency). We investigated the response of hepcidin to increased erythropoiesis and iron deficiency in the presence of an acute inflammation to assess the relative strengths of these stimuli. DESIGN AND METHODS: Sprague-Dawley rats were maintained on control or iron-deficient diets and treated with lipopolysaccharide to induce inflammation or phenylhydrazine to stimulate erythropoiesis. The levels of Hamp, IL-6 and α2m mRNA were determined by qualitative real-time polymerase chain reaction and those of serum interleukin-6 and tumor necrosis factor-α were measured by enzyme-linked immunosorbent assay. Cultured RAW264.7 and HuH7 cells were used in associated studies. RESULTS: The increase in hepatic hepcidin levels induced by lipopolysaccharide was not affected by phenylhydrazine treatment but was blunted by iron deficiency. Lipopolysaccharide-treated iron-deficient animals also showed lower liver α2m mRNA and reduced serum interleukin-6 and tumor necrosis factor-α, suggesting a more generalized effect of iron deficiency. Similarly, RAW 264.7 cells treated with iron chelators and then stimulated with lipopolysaccharide showed lower IL-6 mRNA than cells treated with lipopolysaccharide alone. Huh7 cells treated with an iron chelator showed a blunted hepcidin response to interleukin-6, suggesting that the response of hepatic parenchymal cells to inflammatory cytokines may also be iron-dependent. CONCLUSIONS: In any one physiological situation, net hepcidin levels are determined by the relative strengths of competing stimuli. The ability of severe iron deficiency to blunt the response to lipopolysaccharide of both hepcidin and other markers of inflammation suggests that adequate iron levels are necessary for a full acute phase response.
BACKGROUND: Expression of the key iron regulatory hormone hepcidin is increased by some stimuli (iron loading, inflammation) but decreased by others (increased erythropoiesis, iron deficiency). We investigated the response of hepcidin to increased erythropoiesis and iron deficiency in the presence of an acute inflammation to assess the relative strengths of these stimuli. DESIGN AND METHODS: Sprague-Dawley rats were maintained on control or iron-deficient diets and treated with lipopolysaccharide to induce inflammation or phenylhydrazine to stimulate erythropoiesis. The levels of Hamp, IL-6 and α2m mRNA were determined by qualitative real-time polymerase chain reaction and those of serum interleukin-6 and tumor necrosis factor-α were measured by enzyme-linked immunosorbent assay. Cultured RAW264.7 and HuH7 cells were used in associated studies. RESULTS: The increase in hepatic hepcidin levels induced by lipopolysaccharide was not affected by phenylhydrazine treatment but was blunted by iron deficiency. Lipopolysaccharide-treated iron-deficient animals also showed lower liver α2m mRNA and reduced serum interleukin-6 and tumor necrosis factor-α, suggesting a more generalized effect of iron deficiency. Similarly, RAW 264.7 cells treated with iron chelators and then stimulated with lipopolysaccharide showed lower IL-6 mRNA than cells treated with lipopolysaccharide alone. Huh7 cells treated with an iron chelator showed a blunted hepcidin response to interleukin-6, suggesting that the response of hepatic parenchymal cells to inflammatory cytokines may also be iron-dependent. CONCLUSIONS: In any one physiological situation, net hepcidin levels are determined by the relative strengths of competing stimuli. The ability of severe iron deficiency to blunt the response to lipopolysaccharide of both hepcidin and other markers of inflammation suggests that adequate iron levels are necessary for a full acute phase response.
Authors: D M Frazer; H R Inglis; S J Wilkins; K N Millard; T M Steele; G D McLaren; A T McKie; C D Vulpe; G J Anderson Journal: Gut Date: 2004-10 Impact factor: 23.059
Authors: Elizabeta Nemeth; Erika V Valore; Mary Territo; Gary Schiller; Alan Lichtenstein; Tomas Ganz Journal: Blood Date: 2002-11-14 Impact factor: 22.113
Authors: Toshihiko Tanno; Prashanth Porayette; Orapan Sripichai; Seung-Jae Noh; Colleen Byrnes; Ajoy Bhupatiraju; Y Terry Lee; Julia B Goodnough; Omid Harandi; Tomas Ganz; Robert F Paulson; Jeffery L Miller Journal: Blood Date: 2009-05-04 Impact factor: 22.113
Authors: David M Frazer; Sarah J Wilkins; Erika M Becker; Christopher D Vulpe; Andrew T McKie; Deborah Trinder; Gregory J Anderson Journal: Gastroenterology Date: 2002-09 Impact factor: 22.682
Authors: George Papanikolaou; Mark E Samuels; Erwin H Ludwig; Marcia L E MacDonald; Patrick L Franchini; Marie-Pierre Dubé; Lisa Andres; Julie MacFarlane; Nikos Sakellaropoulos; Marianna Politou; Elizabeta Nemeth; Jay Thompson; Jenni K Risler; Catherine Zaborowska; Ryan Babakaiff; Christopher C Radomski; Terry D Pape; Owen Davidas; John Christakis; Pierre Brissot; Gillian Lockitch; Tomas Ganz; Michael R Hayden; Y Paul Goldberg Journal: Nat Genet Date: 2003-11-30 Impact factor: 38.330
Authors: C Camaschella; A Roetto; A Calì; M De Gobbi; G Garozzo; M Carella; N Majorano; A Totaro; P Gasparini Journal: Nat Genet Date: 2000-05 Impact factor: 38.330
Authors: Asma Siddique; James E Nelson; Bradley Aouizerat; Matthew M Yeh; Kris V Kowdley Journal: Clin Gastroenterol Hepatol Date: 2013-11-20 Impact factor: 11.382
Authors: Sarah H Atkinson; Andrew E Armitage; Shivani Khandwala; Tabitha W Mwangi; Sophie Uyoga; Philip A Bejon; Thomas N Williams; Andrew M Prentice; Hal Drakesmith Journal: Blood Date: 2014-03-04 Impact factor: 22.113
Authors: Peter Peeling; Marc Sim; Claire E Badenhorst; Brian Dawson; Andrew D Govus; Chris R Abbiss; Dorine W Swinkels; Debbie Trinder Journal: PLoS One Date: 2014-03-25 Impact factor: 3.240
Authors: Brie K Fuqua; Yan Lu; Deepak Darshan; David M Frazer; Sarah J Wilkins; Natalie Wolkow; Austin G Bell; JoAnn Hsu; Catherine C Yu; Huijun Chen; Joshua L Dunaief; Gregory J Anderson; Chris D Vulpe Journal: PLoS One Date: 2014-06-04 Impact factor: 3.240